{"data":{"type":"feed_item","id":171629,"entity_id":"wefunder:feed_item:171629","attributes":{"canonical_url":"https://wefunder.com/feed/171629","retrieval_urls":{"canonical":"https://wefunder.com/feed/171629","json":"https://wefunder.com/feed/171629.json","markdown":"https://wefunder.com/feed/171629.md","ai_json":"https://wefunder.com/feed/171629.ai.json","ai_text":"https://wefunder.com/feed/171629.ai.txt","changelog_json":"https://wefunder.com/feed/171629.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2025-07-12T17:44:40.395Z","generated_at":"2026-06-12T23:36:57Z","profile_visibility":"public","feed_item":{"id":171629,"entity_id":"wefunder:feed_item:171629","type":"FeedItem::Update","title":"Kingscrowd Interviews Sen-Jam Co-Founder/CCO Jackie Iversen | Sen-Jam Pharmaceutical","content_plain":"Dear Investors, Colleagues, and Friends, Happy Friday. We've had a great week, and to top it off, we are thrilled that\u0026nbsp;Kingscrowd, the premier data source for alternative investment insight and analytics, will soon feature their interview wit...","published_at":"2024-03-15T19:17:06.509Z","updated_at":"2025-07-12T17:44:40.395Z","canonical_url":"https://wefunder.com/feed/171629","image_url":"https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6NTE2OTcwLCJwdXIiOiJibG9iX2lkIn19--c056352b86f83e3095f4c73191a42ff1cbed1156/feed-item-171629-cover-photo-1710530224138.png","author":{"name":"Jim Iversen","profile_url":"https://wefunder.com/jimiversen2"},"subject":{"name":"Sen-Jam Pharmaceutical","profile_url":"https://wefunder.com/senjam"}},"provenance":{"source":"wefunder_public_feed_item","last_verified_at":"2025-07-12T17:44:40Z","claims":{"title":{"source":"feed_item.title","last_verified_at":"2025-07-12T17:44:40Z","as_of":"2025-07-12T17:44:40Z","confidence":"high"},"published_at":{"source":"feed_item.published_at","last_verified_at":"2025-07-12T17:44:40Z","as_of":"2024-03-15T19:17:06Z","confidence":"high"}}}}}}